What it is
Dural metastasis, in which tumour cells from advanced cancers such as breast and lung cancer infiltrate the dura mater (the tough outermost membrane covering the brain), is a devastating complication that poses clinical challenges distinct from those of brain metastasis, and clinical imaging shows distinctive patterns of erosion in the skull that set it apart from other metastases. In a new mouse model of dural metastasis, the authors found significant impairments in drainage through the meningeal lymphatic vessels as tumours progressed. Single-cell RNA sequencing of the tumour microenvironment highlighted predominant immunosuppressive tactics driven by cancer-related osteoclasts (bone-resorbing cells). Large osteoclasts sit specifically at the interface between skull and tumour, while smaller ones permeate the tumour itself.
Why it matters
In a new mouse model, the study finds a previously unrecognized role, to the authors' knowledge, for failing lymphatic drainage of the meninges in dural metastasis: osteoclasts significantly disrupted the lymphatic paths, angiopoietin-2 they release contributed to the impaired drainage, and targeting them therapeutically restored the structure and function of the meningeal lymphatics and strengthened anti-tumour immune responses. The authors suggest that selectively targeting osteoclasts to restore meningeal lymphatic function could enhance anti-tumour immunity and improve outcomes for patients with dural metastasis.
Every metric behind this entry is listed, with its source, under Sources and data below.
Filed underCerebrospinal fluid and hydrocephalus, Lymphatic System and Diseases, Brain Metastases and Treatment